Clinical Trial Update: Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC)

View source ↗

Summary

Clinical trial comparing pemetrexed/carboplatin versus vinorelbine/carboplatin in patients with completely resected non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Shanghai Nancy Medical Sci-Tech Co. Ltd | Conditions: Non-small Cell Lung Cancer | Status: UNKNOWN